Clinical features of children with venom allergy and risk factors for severe systemic reactions

S Tolga Yavuz1, Umit M Sahiner, Betul Buyuktiryaki

  • 1Pediatric Allergy and Asthma Unit, School of Medicine, Hacettepe University, Ankara, Turkey.

Insights

Severe insect venom allergy reactions in children are rare but linked to wasp venom. Female sex, mild eosinophilia, and atopic disease increase the risk of severe systemic reactions (SRs).

Area of Science:

  • Pediatric Allergy and Immunology
  • Toxicology
  • Clinical Medicine

Background:

  • Severe systemic reactions (SRs) to insect venom are uncommon in children, with limited data available.
  • Understanding risk factors for SRs in pediatric populations is crucial for effective management.

Purpose of the Study:

  • To analyze the clinical features of severe systemic reactions (SRs) in children following insect stings.
  • To identify and document risk factors associated with severe SRs in pediatric insect venom allergy.

Main Methods:

  • Retrospective analysis of children experiencing SRs after Hymenoptera stings.
  • Diagnosis confirmed via medical history, skin tests, and/or specific IgE testing.

Main Results:

  • 76 children (75% male, mean age 9.8 years) studied; 58 with Vespula (wasp) and 18 with Apis mellifera (bee) venom reactions.
  • Severe SRs occurred in 59% of patients. Significant risk factors included eosinophilia (>5%), female sex, and co-existing atopic disease.
  • Epinephrine use was noted in only 46% of patients despite 97% emergency department admission.

Conclusions:

  • Wasp venom hypersensitivity is frequent in this pediatric cohort.
  • Mild eosinophilia, female sex, and atopic diseases are significant risk factors for severe systemic reactions.
  • Identifying these risk factors can optimize healthcare resource allocation for pediatric insect venom allergy.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...